[ Price : $8.95]
Consulting editor John Scharmann receives an unsatisfactory response from CVM about its continued approval of growth-promotant ant...[ Price : $8.95]
FDA extends by up to three months its review of a Novartis NDA for its blood pressure drug Tekturna to allow additional data to be...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to amend its regulations to improve access to investigational drugs for patients with...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to amend its regulations by clarifying the circumstances in which charging for an inv...[ Price : $8.95]
Federal Register Final rule: FDA amends its animal drug regulations to implement the manufacturing changes provisions for suppleme...[ Price : $8.95]
Federal Register Notice: FDAs proposed collection of information on postmarket surveillance has been submited to the Office of Man...[ Price : $8.95]
Federal Register Notice: FDAs LA District and the Society of Clinical Research Associates plan a public workshop 2/7-8 in San Dieg...[ Price : $8.95]
Celgene Corp. says it will file a patent infringement suit against Barr Pharmaceuticals over its ANDA for a generic copy of Thalom...